# Standards for Future Opioid Analgesic Approvals and Incentives for New Therapeutics To Treat Pain and Addiction; Public Hearing; Correction
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Notification of public hearing; request for comments; correction.
**SUMMARY:**
The Food and Drug Administration (FDA) is correcting a notice entitled “Standards for Future Opioid Analgesic Approvals and Incentives for New Therapeutics To Treat Pain and Addiction; Public Hearing” that appeared in the *Federal Register* of June 21, 2019. The document was published with incorrect presenter registration and slide deck submission deadlines. This document corrects those deadlines.
**FOR FURTHER INFORMATION CONTACT:**
Nicole Zelenak, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 6429, Silver Spring, MD 20993-0002, 301-796-9030.
**SUPPLEMENTARY INFORMATION:**
In the *Federal Register* of Friday, June 21, 2019 (84 FR 29112), in FR Doc. 2019-13219, on page 29114, the following correction is made:
On page 29114, in the first column, in the “Presenter” bulleted paragraph, the fourth and fifth sentences “Presenters must register no later than August 9, 2019. Slide decks are due to *[email protected]* in PDF or PowerPoint format no later than August 23, 2019.” are corrected to read “Presenters must register no later than September 6, 2019. Slide decks are due to *[email protected]* in PDF or PowerPoint format no later than September 6, 2019.”
Dated: August 16, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.